# GCC Organ Preservation Market > GCC Organ Preservation Market Research Report: Size, Share, Trend Analysis By Solution (University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, Citrate Solution), By Preservation Techniques (Static Cold Storage, Dynamic Cold Storage), By Organ Type (Kidney, Liver, Heart, Lungs) and By End Users (Hospitals & Clinics, Organ Banks) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.72% - **2024:** $ 8.55 Million - **2025:** $ 9.04 Million - **2035:** $ 15.76 Million - **Key Players:** Organ Recovery Systems (US), TransMedics (US), Xvivo Perfusion (SE), LifeLink Foundation (US), Tissue Regenix (GB), Paragonix Technologies (US), Bridge to Life (US), Preservation Solutions (US) **Report ID:** MRFR/MED/47701-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/gcc-organ-preservation-market-49452 --- ## Market Summary ## **GCC Organ Preservation Market Overview** As per MRFR analysis, the GCC Organ Preservation Market Size was estimated at 16.06 (USD Million) in 2023. The GCC Organ Preservation Market Industry is expected to grow from 17(USD Million) in 2024 to 103 (USD Million) by 2035. The GCC Organ Preservation Market CAGR (growth rate) is expected to be around 17.795% during the forecast period (2025 - 2035). ## **Key GCC Organ Preservation Market Trends Highlighted** The GCC Organ Preservation Market is witnessing several important trends that are shaping its future. The region's growing investment in healthcare infrastructure is significantly enhancing organ preservation technologies. Governments across the GCC are focusing on improving their healthcare systems, which includes the development of advanced organ preservation solutions. This approach aligns with the increasing number of organ transplant surgeries being performed as more patients seek successful outcomes through well-preserved organs. A notable trend is the adoption of innovative preservation techniques, such as hypothermic preservation and machine perfusion, which are supported by local research institutions and hospitals. With rising awareness about organ donation and transplantation, there is a growing public interest in organ preservation. This trend is being fueled by various campaigns led by health ministries in the GCC, promoting the importance of organ donation and its impact on saving lives. The region's demographic shifts, including an aging population and a rise in chronic diseases, highlight an immediate need for efficient organ preservation methods to support transplant programs. Opportunities are present for local companies to collaborate with international players to enhance their capabilities in organ preservation technologies. By focusing on education and training initiatives, the GCC can build a workforce skilled in organ preservation practices. Additionally, leveraging regional research capabilities to innovate and adapt preservation techniques can lead to improved transplant outcomes. Overall, the GCC Organ Preservation Market is poised for growth with a clear shift towards advanced technologies, increased public engagement, and supportive government policies driving the industry forward. Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **GCC Organ Preservation Market Drivers** ### **Rising Demand for Organ Transplants** As chronic illnesses, including diabetes, hypertension, and organ failures, become more common, the Gulf Cooperation Council (GCC) region's need for organ transplants is gradually rising. The Ministry of Public Health of Qatar reports that the prevalence of diabetes has significantly increased, affecting around 16 percent of adults. The GCC Organ Preservation Market Industry is growing as a result of the increase in chronic illnesses, which also increases the need for organ transplants. Over 100 kidney transplants have been performed in the last year alone, according to organizations like the Oman Medical Specialty Board. The need for improved organ preservation techniques is further highlighted by rising public awareness and government programs designed to promote organ donation in nations like Saudi Arabia and Kuwait. ### **Technological Advancements in Preservation Techniques** Recent advancements in organ preservation technologies, such as the development of hypothermic machine perfusion and novel preservation solutions, are expected to drive growth in the GCC Organ Preservation Market Industry. Countries like the United Arab Emirates are seeing investments in innovative medical technologies, with the Health Investment Fund allocating significant resources for Research and Development in organ preservation technology. According to statistics from the Dubai Health Authority, procedures involving advanced preservation techniques have resulted in a 30 percent increase in the successful usage of preserved organs. This technological evolution directly addresses the need for efficient and effective preservation methods, benefiting organ transplant programs across the region. ### **Growing Government Initiatives and Policies** Governments across the GCC region are increasingly recognizing the importance of organ donation and transplantation, which has prompted various initiatives to improve the infrastructure around organ preservation. For instance, the Saudi Center for Organ Transplantation has undertaken comprehensive campaigns to boost organ donation rates by educating citizens about the benefits of organ donation. This is crucial as the region has seen a 50 percent increase in registered organ donors over the last decade. The initiatives not only emphasize the ethical significance of organ donation but also bolster the GCC Organ Preservation Market Industry by ensuring that once organs are donated, they can be effectively preserved and utilized. ### **Increase in Awareness About Organ Donation** Public awareness campaigns about organ donation in the GCC region have been gaining traction, leading to increased participation in organ donation programs. Statistics from the Ministry of Health in Kuwait show that awareness initiatives have led to a rise in registration for organ donation by approximately 40 percent over the last three years. The campaigns often involve partnerships with leading healthcare providers and non-profit organizations to disseminate information. The heightened awareness is critical for the GCC Organ Preservation Market Industry, as it ensures a consistent supply of organs for transplantation, necessitating improved preservation techniques to maximize their viability and success rates. ## **GCC Organ Preservation Market Segment Insights** ### **Organ Preservation Market Solution Insights** The GCC Organ Preservation Market's Solution segment is integral to advancing transplant surgery and organ donation efficiencies, focusing on optimizing the preservation of organs for transplantation. As healthcare systems in the GCC region evolve, the demand for effective organ preservation solutions continues to rise, driven by increasing transplant volumes and the growing need for organ viability during transport. University of Wisconsin Solution is widely acknowledged for its efficacy in preserving various organs, particularly kidneys.Custodial HTK presents a notable alternative with a unique composition designed for optimal heart and liver preservation.Collins Solution is beneficial for both kidney and liver preservation, offering advantages in terms of reducing cellular injury during cold storage. Celsior Solution, known for its oxygen-carrying capacity, enhances organ viability for extended periods and is essential in regions where transportation times are increased. Perfadex is tailored for preserving lungs, where maintaining optimal conditions for organ viability is paramount, reflecting the particular challenges of lung transplantation. Citrate Solution, recognized for its ability to stabilize organs at low temperatures, provides an additional option for preserving organs efficiently during the critical stage of transport. The GCC region's healthcare infrastructure is advancing through investments in organ transplantation technologies, and these solutions play crucial roles in enhancing organ preservation techniques. These advancements ultimately contribute to improved patient outcomes and transplant success rates. The market exhibits substantial growth potential as healthcare providers increasingly prioritize the adoption of these advanced preservation techniques, representing a dynamic area for development and innovation within the broader context of the GCC Organ Preservation Market. Source Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Organ Preservation Market Preservation Techniques Insights** The Preservation Techniques segment within the GCC Organ Preservation Market plays an essential role in ensuring the viability and efficacy of organ transplantation. Notably, methods such as Static Cold Storage and Dynamic Cold Storage are critical for maintaining organ quality during transport. Static Cold Storage remains widely utilized for its simplicity and effective cooling capabilities, preserving organs at lower temperatures to inhibit metabolic processes. Dynamic Cold Storage is emerging as a significant alternative, offering enhanced protection through continuous perfusion, which supplies nutrients and oxygen to the organ, thereby extending its preservation time. The growing number of transplant procedures across the GCC region and the increasing emphasis on organ donation are key drivers behind the demand for advanced preservation techniques. Furthermore, supported by government initiatives aimed at improving healthcare infrastructure and public awareness of organ donation, the market is positioned for robust growth. These preservation techniques ensure that donated organs remain viable for transplantation, significantly impacting patient outcomes and the overall efficiency of healthcare systems in the GCC. Both Static and Dynamic Cold Storage methods represent critical progress in organ preservation, reflecting advancements in medical technology and enhanced patient care strategies. ### **Organ Preservation Market Organ Type Insights** The GCC Organ Preservation Market is experiencing significant growth, propelled by advancements in medical technology and increasing demand for organ transplants. The market is notably segmented by Organ Type, which includes critical organs such as Kidney, Liver, Heart, and Lungs. Kidney preservation segment is particularly vital due to the high prevalence of kidney diseases and the need for effective preservation methods. Liver preservation is gaining attention because of the rise in liver-related ailments, prompting innovative preservation techniques. Heart preservation is also a focal point, as the growing number of cardiovascular disorders emphasizes the necessity for efficient heart transplant procedures. Lungs are becoming increasingly prioritized due to an uptick in pulmonary diseases and the need for optimal conditions. The increasing awareness of organ transplantation and improvements in preservation techniques are driving the overall demand in the GCC region. This provides ample opportunities for market players to innovate and meet growing healthcare needs. The GCC Organ Preservation Market revenue reflects these evolving dynamics, fueled by regulatory support and increased investments in healthcare infrastructure. ### **Organ Preservation Market End User Insights** The End User segment of the GCC Organ Preservation Market plays a crucial role in the overall ecosystem, primarily encompassing Hospitals and Clinics, as well as Organ Banks. Hospitals and Clinics are pivotal as they are the primary facilitators in organ transplantation processes, requiring efficient preservation techniques to enhance organ viability and reduce the risk of rejection. The growing demand for organ transplants within the Gulf Cooperation Council (GCC) region has led to an increased focus on optimizing preservation techniques. Organ Banks serve as critical repositories for harvested organs, necessitating advanced preservation technologies to maintain organ integrity during storage and transportation. The collaboration between these End Users is essential for enhancing transplantation rates and improving patient outcomes, thereby driving growth within the GCC Organ Preservation Market. Moreover, increasing awareness about organ donation and supporting legislation in various GCC nations are significant contributors to the evolution of this market. This reflects a commitment to address the organ shortage crisis and promote public health initiatives across the region. ## **GCC Organ Preservation Market Key Players and Competitive Insights** The GCC Organ Preservation Market is characterized by a dynamic landscape where innovation and strategic positioning dictate competitive advantage. The burgeoning demand for organ transplantation and the critical need for effective preservation techniques have propelled various stakeholders to enhance their capabilities. Companies within this market are focusing on developing advanced preservation solutions that extend the viability of organs while improving their functional quality. With a rising prevalence of organ transplantation due to chronic diseases and an increasing number of patients requiring such procedures, competition in this sector has become intense. Organizations are leveraging technology and research collaboration to introduce novel methodologies for organ preservation, which are anticipated to drive market growth significantly. ### **Bellicum Pharmaceuticals** Bellicum Pharmaceuticals has carved out a notable presence in the GCC Organ Preservation Market through its innovative approach to cellular therapies and organ preservation solutions. The company's strengths lie in its cutting-edge research and development initiatives aimed at optimizing organ preservation methodologies. Bellicum Pharmaceuticals has established strong channels for collaboration with healthcare institutions and organ transplant centers across the GCC region, showcasing its commitment to advancing preservation technologies. By emphasizing rigorous clinical trials and extensive data analysis, the company enhances its product offerings to better meet the unique needs of healthcare professionals and patients alike. This rigorous approach solidifies its competitive position in this niche market. ### **TransMedics** TransMedics has made significant strides in the GCC Organ Preservation Market by introducing advanced organ preservation systems designed to maintain the viability of organs during transportation and transplantation. The company's key products, such as portable organ preservation devices, are engineered to cater specifically to the needs of transplant surgeons in the GCC region, allowing for more successful transplant outcomes. TransMedics has established a strong market presence through partnerships with leading hospitals and transplant centers, leveraging these relationships to foster acceptance and trust in its technologies. The company's strengths include its focus on innovation, robust clinical evidence supporting its products, and an ongoing commitment to research and development. Additionally, TransMedics’ strategic mergers and acquisitions have enhanced its capabilities and market reach in the GCC, positioning it as a trusted player in organ preservation solutions. ### **Key Companies in the GCC Organ Preservation Market Include** ## **GCC Organ Preservation Market Industry Developments** The GCC [Organ Preservation Market](../../../reports/organ-preservation-market-6073)has witnessed significant developments recently, particularly with technological advancements and increased investments in organ preservation solutions. In September 2023, United Therapeutics announced a collaboration with Xvivo Perfusion to enhance its organ preservation capabilities, focusing on lungs and hearts, which reflects the growing emphasis on improving transplant outcomes. Furthermore, Bellicum Pharmaceuticals is expanding its portfolio in the region, aligning with local healthcare initiatives to boost organ transplantation efficiency. In terms of market valuation, companies like Thermo Fisher Scientific and LifeNet Health have seen growth, enhancing their product lines and expanding their services to meet rising demands within the GCC healthcare sectors. Additionally, noteworthy merger and acquisition activities have taken place, notably, in August 2023, Baxter International announced its strategic acquisition of Alliance BioEnergy to strengthen its position within the organ preservation technology space. The ongoing investment in Research and Development by these key players is contributing to the overall dynamism of the GCC Organ Preservation Market, aligning with the region's vision to enhance healthcare services and transplantation effectiveness. ## **GCC Organ Preservation Market Segmentation Insights** ### **Organ Preservation Market Solution Outlook** ### **Organ Preservation Market Preservation Techniques Outlook** ### **Organ Preservation Market Organ Type Outlook** ### **Organ Preservation Market End User Outlook** ## Market Drivers ### Increasing Healthcare Expenditure The rising healthcare expenditure in the GCC region is a pivotal driver for the organ preservation market. Governments are allocating more funds towards healthcare infrastructure, which includes organ transplant facilities and preservation technologies. In 2025, healthcare spending in the GCC is projected to reach approximately $100 billion, reflecting a growth rate of around 5% annually. This increase in funding is likely to enhance the capabilities of hospitals and clinics, thereby improving organ preservation methods. Enhanced healthcare facilities can lead to better organ storage solutions, which are crucial for successful transplants. As a result, the organ preservation market is expected to benefit from this trend, as more resources are directed towards advanced preservation techniques and technologies. ### Growing Awareness of Organ Donation There is a notable increase in awareness regarding organ donation across the GCC, which is significantly influencing the organ preservation market. Educational campaigns and initiatives by health authorities are fostering a culture of organ donation, which is essential for addressing the shortage of available organs. As awareness grows, the demand for effective preservation methods becomes more pronounced. In 2025, it is estimated that organ donation rates in the GCC could increase by 15%, leading to a higher need for preservation solutions. This heightened awareness not only encourages more individuals to register as organ donors but also emphasizes the importance of preserving organs for successful transplantation, thereby driving growth in the organ preservation market. ### Rising Incidence of Chronic Diseases The increasing incidence of chronic diseases in the GCC is a significant driver for the organ preservation market. Conditions such as diabetes and hypertension are leading to a higher demand for organ transplants, as these diseases often result in organ failure. In 2025, it is projected that the prevalence of chronic diseases in the region will rise by 10%, further straining the existing organ supply. This growing demand necessitates effective organ preservation techniques to ensure that available organs can be stored for longer periods. Consequently, the organ preservation market is expected to expand as healthcare providers seek to improve preservation methods to meet the rising demand for transplants. ### Regulatory Support for Organ Preservation Regulatory support plays a crucial role in shaping the organ preservation market in the GCC. Governments are implementing policies that promote organ donation and transplantation, which indirectly supports the need for effective preservation methods. In 2025, it is anticipated that new regulations will be introduced to standardize preservation techniques and ensure the safety and efficacy of organ storage. This regulatory framework is expected to enhance the credibility of preservation methods, encouraging more healthcare facilities to invest in advanced technologies. As a result, the organ preservation market is likely to expand, driven by the need for compliance with these regulations and the growing emphasis on patient safety. ### Technological Innovations in Preservation Solutions Technological innovations are transforming the organ preservation market, particularly in the GCC region. The introduction of advanced preservation solutions, such as hypothermic machine perfusion and novel preservation solutions, is enhancing the viability of organs during storage. These technologies can extend the preservation time significantly, which is crucial for successful transplants. In 2025, the market for these innovative preservation technologies is expected to grow by approximately 20%, driven by the increasing demand for organ transplants. As hospitals and transplant centers adopt these cutting-edge solutions, the organ preservation market is likely to experience substantial growth, reflecting the importance of technology in improving transplant outcomes. ## Future Outlook The [Organ Preservation Market](https://www.marketresearchfuture.com/reports/organ-preservation-market-6073) is projected to grow at a 5.72% CAGR from 2025 to 2035, driven by technological advancements, increasing organ transplant demand, and enhanced preservation techniques. **New opportunities:** - Development of advanced hypothermic preservation solutions for extended organ viability. - Implementation of AI-driven logistics for efficient organ transport and tracking. - Partnerships with hospitals for integrated organ preservation and transplantation services. By 2035, the organ preservation market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Solution: University of Wisconsin Solution (Largest) vs. Custodial HTK (Fastest-Growing) In the GCC organ preservation market, the University of Wisconsin Solution holds the largest share, highlighting its widespread acceptance and reliability among medical professionals. Following closely is the Custodial HTK, which, while not as widely adopted, is experiencing rapid growth due to its effectiveness and advancements in preservation technology. Other solutions such as Collins Solution, Celsior Solution, Perfadex, and Citrate Solution have contributed to the diverse landscape of organ preservation, each claiming unique advantages. Growth trends in this segment are influenced by technological innovations and an increasing emphasis on successful transplantation outcomes. The Custodial HTK is gaining traction due to its enhanced preservation capabilities, while the University of Wisconsin Solution remains a preferred choice, reflecting a strong legacy in organ preservation. Regulatory developments and rising organ transplant rates are further expected to boost demand for these solutions in the coming years. University of Wisconsin Solution (Dominant) vs. Custodial HTK (Emerging) The University of Wisconsin Solution stands out as the dominant player in the GCC organ preservation market, known for its superior preservation efficacy and extensive use in clinical settings. Its formula has a proven track record in extending organ viability, making it a preferred choice among surgeons. In contrast, Custodial HTK, though emerging, is rapidly gaining recognition for its unique formulation that enhances preservation quality. This dual characteristic makes it especially popular for certain organ types, such as the liver. As healthcare providers seek improved outcomes, both solutions are integral in ensuring optimal results during the transplant process, showcasing their respective market positions and future potential. ### By Preservation Techniques: Static Cold Storage (Largest) vs. Dynamic Cold Storage (Fastest-Growing) The GCC organ preservation market exhibits a distinct structure, with Static Cold Storage commanding a significant share as the largest segment in terms of usage. It serves as the conventional method widely adopted across various healthcare facilities, primarily due to its reliability and proven effectiveness in organ preservation. In contrast, Dynamic Cold Storage is gaining traction, appealing to facilities eager to innovate and improve the outcomes of organ transplantation. Rapid developments in technology and a growing emphasis on improving organ transplant success rates are propelling the growth of Dynamic Cold Storage. This segment is characterized by more advanced methodologies that allow for better metabolic control of organs, which is crucial for maintaining viability during transport. As healthcare providers prioritize better preservation techniques, Dynamic Cold Storage is expected to climb in prominence, indicating a robust trend towards modernization within the GCC organ preservation market. Preservation Techniques: Static Cold Storage (Dominant) vs. Dynamic Cold Storage (Emerging) Static Cold Storage remains the dominant technique in the GCC organ preservation market, revered for its direct and established methodology in preserving organs at lower temperatures. Its widespread acceptance stems from decades of successful use, making it a trusted choice among healthcare providers. On the other hand, Dynamic Cold Storage is emerging as a compelling alternative, utilizing advanced technologies to enhance organ viability. This technique is especially appealing to transplant centers looking to optimize outcomes through innovative methods, thus illustrating a shift towards more sophisticated preservation options as the market evolves. ### By Organ Type: Kidney (Largest) vs. Liver (Fastest-Growing) In the GCC organ preservation market, the distribution of market share among organ types reveals that the kidney segment holds the largest share, underscoring its critical role in organ transplantation procedures. The liver segment follows, showcasing significant importance, while both heart and lung segments occupy smaller niches, yet remain vital for comprehensive organ preservation efforts. Each organ type's unique characteristics influence its market dynamics and preservation needs, leading to varied developments across the sector. Growth trends in the organ preservation segment highlight the liver as the fastest-growing organ due to rising transplantation rates and advancements in preservation technology. Factors driving this growth include increased awareness about organ donation, improvements in healthcare infrastructure, and the ongoing development of preservation solutions that enhance viability. As the demand for transplants continues to rise, the kidney and liver segments are positioned for substantial growth and innovation in preservation methodologies. Kidney (Dominant) vs. Liver (Emerging) The kidney segment is the dominant force in the organ preservation market, reflecting its critical importance in transplantation. Renowned for its extensive research and development backing, this segment benefits from established protocols and technologies that enhance preservation efficacy. In contrast, the liver segment is emerging rapidly, driven by innovations in preservation techniques that extend organ viability. Both segments exhibit distinct characteristics; kidneys are often sourced from living donors, while liver preservation emphasizes techniques that support longer storage times. Together, they represent the dual pillars of a healthcare approach that prioritizes increasing successful transplantation rates in the GCC organ preservation market. ### By End-User: Hospitals & Clinics (Largest) vs. Organ Banks (Fastest-Growing) In the GCC organ preservation market, the end-user segment is primarily dominated by hospitals and clinics, which account for the largest share in terms of utilization and need for organ preservation solutions. These facilities are crucial as they directly handle organ transplantation, thus driving significant demand for preservation technologies. In contrast, organ banks, although smaller in market share, are witnessing rapid growth as they expand their capabilities in organ storage and preservation, responding to an increasing number of transplant procedures. Hospitals & Clinics (Dominant) vs. Organ Banks (Emerging) Hospitals and clinics stand out as the dominant end-users in the GCC organ preservation market due to their critical roles in organ transplantation and patient care. They have established robust infrastructures and protocols for organ preservation, ensuring high standards of care and successful transplant outcomes. On the other hand, organ banks are emerging as key players, expanding their services and technologies to optimize the preservation process. This growth is fueled by regulatory advancements and increasing awareness of the importance of organ preservation, highlighting the need for specialized solutions in this sector. ## Competitive Benchmarking The organ preservation market is currently characterized by a dynamic competitive landscape, driven by advancements in technology and increasing demand for organ transplants. Key players are focusing on innovation and strategic partnerships to enhance their operational capabilities. For instance, Organ Recovery Systems (US) has positioned itself as a leader in the development of preservation solutions that extend organ viability, while TransMedics (US) emphasizes its cutting-edge organ perfusion technology, which is pivotal in improving transplant outcomes. These strategies collectively contribute to a competitive environment that is increasingly focused on technological advancements and operational efficiency.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The market appears moderately fragmented, with several key players exerting influence over specific segments. This fragmentation allows for niche players to thrive, while larger companies leverage their resources to establish a more significant market presence. The collective influence of these key players shapes the market structure, fostering an environment where innovation and strategic collaborations are paramount. In October Xvivo Perfusion (SE) announced a strategic partnership with a leading research institution to develop next-generation organ preservation technologies. This collaboration is expected to enhance their product offerings and solidify their position in the market. The strategic importance of this partnership lies in its potential to accelerate innovation and improve the efficacy of organ preservation solutions, thereby addressing the growing demand for transplantable organs. In September LifeLink Foundation (US) launched a new initiative aimed at increasing awareness and education around organ donation and preservation. This initiative is crucial as it not only enhances their brand visibility but also aligns with their mission to improve organ donation rates. By focusing on education, LifeLink Foundation is likely to foster a more informed public, which could lead to increased organ availability and ultimately benefit their operational goals. In August Paragonix Technologies (US) expanded its product line with the introduction of a new organ preservation device designed for heart transplants. This expansion reflects a strategic move to diversify their offerings and cater to the specific needs of heart transplant procedures. The introduction of this device is significant as it addresses a critical area in organ transplantation, potentially improving patient outcomes and enhancing the company's competitive edge. As of November current trends in the organ preservation market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) in operational processes. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of developing robust, sustainable solutions that meet the evolving needs of the healthcare sector. ## Recent News & Developments The GCC [Organ Preservation Market](../../../reports/organ-preservation-market-6073)has witnessed significant developments recently, particularly with technological advancements and increased investments in organ preservation solutions. In September 2023, United Therapeutics announced a collaboration with Xvivo Perfusion to enhance its organ preservation capabilities, focusing on lungs and hearts, which reflects the growing emphasis on improving transplant outcomes. Furthermore, Bellicum Pharmaceuticals is expanding its portfolio in the region, aligning with local healthcare initiatives to boost organ transplantation efficiency. In terms of market valuation, companies like Thermo Fisher Scientific and LifeNet Health have seen growth, enhancing their product lines and expanding their services to meet rising demands within the GCC healthcare sectors. Additionally, noteworthy merger and acquisition activities have taken place, notably, in August 2023, Baxter International announced its strategic acquisition of Alliance BioEnergy to strengthen its position within the organ preservation technology space. The ongoing investment in Research and Development by these key players is contributing to the overall dynamism of the GCC Organ Preservation Market, aligning with the region's vision to enhance healthcare services and transplantation effectiveness. ## Report Scope | MARKET SIZE 2024 | 8.55(USD Million) | | --- | --- | | MARKET SIZE 2025 | 9.04(USD Million) | | MARKET SIZE 2035 | 15.76(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.72% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Organ Recovery Systems (US), TransMedics (US), Xvivo Perfusion (SE), LifeLink Foundation (US), Tissue Regenix (GB), Paragonix Technologies (US), Bridge to Life (US), Preservation Solutions (US) | | Segments Covered | Solution, Preservation Techniques, Organ Type, End-User | | Key Market Opportunities | Advancements in preservation techniques enhance organ viability, addressing critical shortages in transplantation. | | Key Market Dynamics | Rising demand for advanced organ preservation technologies driven by regulatory support and increasing transplantation needs in the GCC. | | Countries Covered | GCC | ## Frequently Asked Questions **Q: What was the overall market valuation of the organ preservation market in 2024?** A: The overall market valuation was 8.55 $ Million in 2024. **Q: What is the projected market valuation for the organ preservation market by 2035?** A: The projected valuation for 2035 is 15.76 $ Million. **Q: What is the expected CAGR for the organ preservation market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during the forecast period 2025 - 2035 is 5.72 %. **Q: Which organ types are included in the organ preservation market, and what were their valuations in 2024?** A: In 2024, the valuations for organ types were Kidney: 2.55 $ Million, Liver: 2.0 $ Million, Heart: 2.0 $ Million, and Lungs: 2.0 $ Million. **Q: What are the key solutions used in organ preservation, and how did their valuations compare in 2024?** A: In 2024, the valuations for key solutions included Citrate Solution: 3.85 $ Million, University of Wisconsin Solution: 1.5 $ Million, and Custodial HTK: 1.2 $ Million. **Q: What preservation techniques are utilized in the organ preservation market, and what were their valuations in 2024?** A: In 2024, Static Cold Storage was valued at 3.42 $ Million, while Dynamic Cold Storage reached 5.13 $ Million. **Q: Who are the key players in the organ preservation market?** A: Key players in the market include Organ Recovery Systems, TransMedics, Xvivo Perfusion, and LifeLink Foundation. **Q: What are the end-user segments in the organ preservation market, and what were their valuations in 2024?** A: In 2024, Hospitals & Clinics were valued at 5.13 $ Million, while Organ Banks reached 3.42 $ Million. **Q: How do the valuations of organ preservation solutions vary among different types?** A: In 2024, Citrate Solution had the highest valuation at 3.85 $ Million, followed by University of Wisconsin Solution at 1.5 $ Million. **Q: What trends are anticipated in the organ preservation market as it approaches 2035?** A: As the market approaches 2035, it is likely to see growth driven by advancements in preservation techniques and increasing demand for organ transplants. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/gcc-organ-preservation-market-49452*